FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression

Atsushi Okato(Chiba University), William Y. Kim(University of North Carolina at Chapel Hill)
Journal of Clinical Investigation
January 15, 2024
Cited by 27


Related Papers